FDA.reportPublic FDA data

RIVASTIGMINE

Substance profile for UNII PKI06M3IW0, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for RIVASTIGMINE
Structure render from PubChem CID 77991

Substance Identity#

UNII
PKI06M3IW0
Preferred term
RIVASTIGMINE
Registry number
123441-03-2
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C14H22N2O2
Chemical structure for RIVASTIGMINE
Structure render from PubChem CID 77991

Chemical And Database Identifiers#

InChIKey
XSVMFMHYUFZWBK-NSHDSACASA-N
SMILES
CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
RxCUI
183379
PubChem
77991
NCIt
C66519
INN ID
7562

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound77991pubchem.ncbi.nlm.nih.gov/compound/77991
PubChem InChIKey SearchXSVMFMHYUFZWBK-NSHDSACASA-Npubchem.ncbi.nlm.nih.gov/#query=XSVMFMHYUFZWBK-NSHDSACASA-N
RxNorm183379mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=183379
NCI ThesaurusC66519ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66519
FDA Substance Registration SystemPKI06M3IW0precision.fda.gov/uniisearch/srs/unii/PKI06M3IW0

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYThese highlights do not include all the information needed to use Rivastigmine Tartrate Capsules safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules. Rivastigmine Tartrate Capsules, for oral use Initial U.S. Approval: 20002
ACTIVE MOIETYExelon1
ACTIVE INGREDIENTExelon1
ACTIVE MOIETYRivastigmine Tartrate Capsules1
ACTIVE MOIETYfead084a-a376-4d57-bdf0-aa7ed36555051
ACTIVE MOIETY29481887-34eb-460a-bd7f-b8755473065a2
ACTIVE INGREDIENT29481887-34eb-460a-bd7f-b8755473065a2
ACTIVE INGREDIENTEXELON (RIVASTIGMINE) PATCH, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION]16
ACTIVE MOIETYEXELON (RIVASTIGMINE) PATCH, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION]16
ACTIVE MOIETYEXELON (RIVASTIGMINE TARTRATE) CAPSULE EXELON (RIVASTIGMINE TARTRATE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION]14
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [APOTEX CORP.]8
ACTIVE INGREDIENTRIVASTIGMINE TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [ALVOGEN INC.]8
ACTIVE MOIETYRIVASTIGMINE TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [ALVOGEN INC.]8
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [WATSON LABORATORIES, INC.]7
ACTIVE MOIETYRIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE ) CAPSULE [DR. REDDY'S LABORATORIES LIMITED]6
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [BRECKENRIDGE PHARMACEUTICAL, INC]6
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]5
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [CARILION MATERIALS MANAGEMENT]3
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [AMERICAN HEALTH PACKAGING]2
ACTIVE INGREDIENTRIVASTIGMINE PATCH, EXTENDED RELEASE [SANDOZ INC]1
ACTIVE MOIETYRIVASTIGMINE PATCH, EXTENDED RELEASE [SANDOZ INC]1
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [ALEMBIC PHARMACEUTICALS LIMITED]1
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.]1
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [MACLEODS PHARMACEUTICALS LIMITED]1
ACTIVE MOIETYRIVASTIGMINE TARTRATE CAPSULE [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]1